ArticleJournal of pharmaceutical sciences2021

Insilico drug repurposing using FDA approved drugs against Membrane protein of SARS-CoV-2.

K Abraham Peele et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.